Cytokeratin 6D Inhibitors
Cytokeratin 6D inhibitors are a class of compounds designed to target cytokeratin 6D, a member of the cytokeratin family, which consists of intermediate filament proteins critical for providing structural support and mechanical stability in epithelial cells. Cytokeratin 6D, in particular, is one of the type II keratins, typically expressed in certain stratified epithelial tissues, such as the hair follicles and specific areas of the skin. This protein plays a role in the structural organization of the cytoskeleton, helping to maintain cell integrity and resilience against mechanical stress. Inhibitors of cytokeratin 6D interfere with its normal function, leading to changes in the assembly and dynamics of the cytoskeletal network.
Cytokeratin 6D is composed of alpha-helical rod domains that enable the formation of intermediate filaments through heterodimerization with other cytokeratin proteins. Inhibitors of cytokeratin 6D may bind to key regions of the protein, preventing its interaction with other keratin molecules or disrupting the polymerization of filaments. By inhibiting the function of cytokeratin 6D, these compounds can alter the mechanical properties of epithelial cells, affecting cell shape, stability, and organization within tissues. Studying cytokeratin 6D inhibitors provides important insights into the role of intermediate filaments in cellular structure, as well as how keratin networks contribute to the mechanical resilience of epithelial tissues under stress. These inhibitors serve as valuable tools for dissecting the molecular pathways governing cytoskeletal dynamics and epithelial cell organization.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor could lead to the hypomethylation of promoter regions of genes that suppress the transcription of Cytokeratin 6D, resulting in its decreased synthesis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylases, Trichostatin A may cause the chromatin to remain in a tightly packed state, reducing the accessibility of transcription machinery to the Cytokeratin 6D gene, thereby decreasing its expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid could initiate cellular differentiation that often entails the downregulation of certain cytoskeletal elements, including Cytokeratin 6D, to support the formation of specialized cell types. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may interfere with specific transcription factors or signal transduction pathways that are essential for the maintenance of Cytokeratin 6D expression, leading to reduced transcription of the gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an inhibitor of the mTOR pathway, Rapamycin may reduce the overall rate of protein synthesis, which could include a decrease in the synthesis of Cytokeratin 6D as part of a broader attenuation of cellular growth and metabolism. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone could disrupt mineralocorticoid receptor-mediated transcription of target genes, potentially leading to a secondary decrease in Cytokeratin 6D expression due to altered cellular signaling. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane might deactivate certain transcription factors, resulting in the downregulation of their target genes, which could include genes responsible for the expression of Cytokeratin 6D. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
This compound may activate sirtuins leading to deacetylation of transcription factors, thereby repressing the expression of target genes, potentially including those that govern the expression of Cytokeratin 6D. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
By inhibiting ribonucleotide reductase, Hydroxyurea could limit the availability of dNTPs, essential for DNA synthesis and repair, possibly resulting in the reduced transcriptional activity of the Cytokeratin 6D gene. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin may activate AMP-activated protein kinase (AMPK), which can lead to a downregulation of protein synthesis pathways, including those involved in the expression of Cytokeratin 6D. | ||||||